News For Allergan


This RSS feed URL is deprecated

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google 24/05/2018 17:24:43

Taking a Fresh Look at Allergan plc (AGN) - StockNewsJournal


StockNewsJournal

Taking a Fresh Look at Allergan plc (AGN)
StockNewsJournal
Allergan plc (AGN) is an interesting player in the Healthcare space, with a focus on Drugs – Generic. The stock has been active on the tape, currently trading at $155.95, up from yesterday's close by 0.63%. Given the stock's recent action, it seemed ...
Is it time to Buy Allergan plc (AGN) and Sysco Corporation (SYY) on the Dip?NMSU Nеws
What the Numbers Say About: Allergan plc, (NYSE: AGN), S&P Global Inc., (NYSE: SPGI)Global Export Lines (press release)
Allergan (AGN) Shares Bought by Markston International LLCMacon Daily
The Ledger Gazette -StockNewsTimes -registrarjournal.com
all 20 news articles »
Google 24/05/2018 16:42:00

Top Wall Street Healthcare Gainers For May: Allergan, CVS Health, Patterson, Sanofi, And Gilead - Seeking Alpha


Top Wall Street Healthcare Gainers For May: Allergan, CVS Health, Patterson, Sanofi, And Gilead
Seeking Alpha
Big pharma drug makers continue to top this sector by yield. However, some mid-cap and nano-cap firms seem better. The healthcare sector is composed of 10 component industries. Here, the top 31 firms selected by Wall Street targets (WallStars) ...

Google 24/05/2018 16:24:00

Allergan Acquires Anti-Depressant Drug Candidate - Pharmaceutical Technology Magazine


Zacks.com

Allergan Acquires Anti-Depressant Drug Candidate
Pharmaceutical Technology Magazine
Under terms of their collaboration, Allergan was granted option rights to a limited number of small molecules from Aptinyx's discovery platform. The research collaboration was initiated in conjunction with Allergan's 2015 acquisition of Naurex, from ...
Allergan Stock Down Since Q1 Earnings Report: Here's WhyZacks.com
Has Allergan plc (NYSE:AGN) Improved Earnings Growth In Recent Times?Simply Wall St
Analysts Shared Their Read on 2 Stocks: Allergan plc (AGN), STMicroelectronics NV (STM)Post Analyst
StockNewsJournal -StockNewsGazette -The Ledger Gazette
all 116 news articles »
Google 23/05/2018 21:22:42

Major Depressive Disorder Targeted Under Allergan Compound Acquisition - Pharmaceutical Processing


Major Depressive Disorder Targeted Under Allergan Compound Acquisition
Pharmaceutical Processing
Allergan plc has exercised its option to acquire drug candidate AGN-241751, an oral small-molecule N-methyl-D-aspartate (NMDA) receptor modulator, from Aptinyx Inc., a clinical-stage biopharmaceutical company. Aptinyx discovered AGN-241751 utilizing ...

Google 23/05/2018 09:11:18

Allergan bulks up on NMDAs as depression landscape shifts - BioWorld Online


BioWorld Online

Allergan bulks up on NMDAs as depression landscape shifts
BioWorld Online
Allergan plc exercised its option to acquire AGN-241751, an oral small-molecule N-methyl-D-aspartate (NMDA) receptor modulator that was discovered by Aptinyx Inc. and advanced under an ongoing research collaboration between the companies. Allergan ...

Google 22/05/2018 23:45:48

BRIEF-Allergan Exercises Option To Acquire Compound From Aptinyx Discovery Platform - Reuters


BRIEF-Allergan Exercises Option To Acquire Compound From Aptinyx Discovery Platform
Reuters
APTINYX - ALLERGAN EXERCISED OPTION TO ACQUIRE DRUG CANDIDATE AGN-241751, AN ORAL SMALL-MOLECULE N-METHYL-D-ASPARTATE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com).

Google 22/05/2018 12:53:30

Allergan Exercises Option to Acquire Compound from Aptinyx Discovery Platform Under Ongoing Research ... - PR Newswire (press release)


FierceBiotech

Allergan Exercises Option to Acquire Compound from Aptinyx Discovery Platform Under Ongoing Research ...
PR Newswire (press release)
EVANSTON, Ill., May 22, 2018 /PRNewswire/ -- Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced Allergan plc (NYSE: AGN) has exercised its option to acquire ...
Allergan acquires NMDA depression drug from Aptinyx collaborationFierceBiotech
Allergan doubles down on NMDA depression drug development ...Endpoints News
Allergan nabs rights to new antidepressant compoundSeeking Alpha
StreetInsider.com -Odessa American
all 5 news articles »
Google 22/05/2018 12:09:17

 1 2